Metastatic Neuroendocrine Neoplasm
2 clinical trials · Condition
◉ Watch Metastatic Neuroendocrine Neoplasm
| Record | Firm | Date |
|---|---|---|
| Telotristat Ethyl for the Treatment of Carcinoid Heart Disease in Patients With Metastatic Neuroendocrine Tumor (NCT04810091) | M.D. Anderson Cancer Center | 2021-05-18 |
| Testing the Combination of XL184 (Cabozantinib), Nivolumab, and Ipilimumab for Poorly Differentiated Neuroendocrine Tumors (NCT04079712) | National Cancer Institute (NCI) | 2020-08-06 |
Track Metastatic Neuroendocrine Neoplasm automatically
Every clearance here is in the API, with alerts when new ones post.